Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

JMV-7488, a new 68Ga-radiolabeled peptide analogue for cancer imaging

Oct. 28, 2021

[18F]-TFB radiotracer useful for PET imaging of glioblastoma

Oct. 6, 2021

Assessing pharmacologic activity of PD(L)-1 MAb therapeutics in tumors by target pharmacodynamics

Sep. 29, 2021

OncoNano expands research collaboration with UTSW on novel cancer therapeutics

Sep. 23, 2021

NIH develops PET radioligands targeting CSF-1R for neuroinflammation

Sep. 9, 2021

[44Sc]Sc-B28110 shows preclinical promise as a radiotracer for the imaging of prostate cancer

Sep. 8, 2021

[11C]PDE7-136 as new PET neuroimaging candidate

Sep. 6, 2021

Scientists discover and characterize a selective hCYP11B2 PET tracer for primary hyperaldosteronism

Aug. 31, 2021

Phase I trial evaluates [11C]YJH-08 PET imaging of GR expression in metastatic prostate cancer

Aug. 26, 2021

First-in-human data reported for [68Ga]iPSMA-BN in healthy subjects

Aug. 24, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...